Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2013 4
2014 1
2015 3
2016 9
2017 7
2018 1
2019 4
2020 5
2021 4
2022 6
2023 1
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Exploring sexual function in adrenal insufficiency: findings from the Dual RElease hydrocortisone versus conventionAl glucocorticoid replaceMent therapy in hypocortisolism (DREAM) trial.
Hasenmajer V, De Alcubierre D, Ferrari D, Minnetti M, Bonaventura I, Pofi R, Simeoli C, Tomaselli A, Sciarra F, Bottillo G, Angelini F, Cozzolino A, Venneri MA, Jannini EA, Gianfrilli D, Pivonello R, Isidori AM. Hasenmajer V, et al. Among authors: simeoli c. Andrology. 2024 Mar 28. doi: 10.1111/andr.13635. Online ahead of print. Andrology. 2024. PMID: 38545799
Severe impact of late diagnosis of congenital adrenal hyperplasia on gender identity, sexual orientation and function: case report and review of the literature.
Simeoli C, de Angelis C, Delli Veneri A, Menafra D, Di Paola N, Pivonello C, Di Somma C, Valerio P, Melis D, Alviggi C, Colao A, Pivonello R. Simeoli C, et al. Front Genet. 2022 Oct 31;13:902844. doi: 10.3389/fgene.2022.902844. eCollection 2022. Front Genet. 2022. PMID: 36386789 Free PMC article.
Susceptibility and characteristics of infections in patients with glucocorticoid excess or insufficiency: the ICARO tool.
Minnetti M, Hasenmajer V, Sbardella E, Angelini F, Simeoli C, Di Paola N, Cozzolino A, Pivonello C, De Alcubierre D, Chiloiro S, Baldelli R, De Marinis L, Pivonello R, Pofi R, Isidori AM. Minnetti M, et al. Among authors: simeoli c. Eur J Endocrinol. 2022 Oct 13;187(5):719-731. doi: 10.1530/EJE-22-0454. Print 2022 Nov 1. Eur J Endocrinol. 2022. PMID: 36102827 Free PMC article.
Cushing's disease: adrenal steroidogenesis inhibitors.
Pivonello R, Simeoli C, Di Paola N, Colao A. Pivonello R, et al. Among authors: simeoli c. Pituitary. 2022 Oct;25(5):726-732. doi: 10.1007/s11102-022-01262-8. Epub 2022 Aug 29. Pituitary. 2022. PMID: 36036308 Free PMC article. Review.
Glucocorticoid Receptor Antagonism Upregulates Somatostatin Receptor Subtype 2 Expression in ACTH-Producing Neuroendocrine Tumors: New Insight Based on the Selective Glucocorticoid Receptor Modulator Relacorilant.
Pivonello R, Munster PN, Terzolo M, Ferrigno R, Simeoli C, Puglisi S, Bali U, Moraitis AG. Pivonello R, et al. Among authors: simeoli c. Front Endocrinol (Lausanne). 2022 Jan 4;12:793262. doi: 10.3389/fendo.2021.793262. eCollection 2021. Front Endocrinol (Lausanne). 2022. PMID: 35058882 Free PMC article.
41 results